Finding the Balance Between Earlier Access and Regulatory Risk in Hospice Length of Stay

One of the most complex conversations in hospice today continues to center around length of stay. When should a patient be admitted? How early is too early? And how can organizations ensure patients receive the full benefit of hospice while also maintaining compliance with Medicare requirements?

Having worked alongside hospice teams, clinicians, and administrators in several different roles, I have seen firsthand how challenging this balance can be. Hospice leaders are constantly navigating two priorities that sometimes feel at odds with one another: providing timely, compassionate care while ensuring every admission and recertification is supported by strong clinical documentation.

The good news is these goals are not mutually exclusive. Hospice was never intended to be reserved only for the final days of life. Earlier access allows patients and families to benefit from symptom management, caregiver education, emotional support, advance care planning, and the expertise of the interdisciplinary team. At the same time, organizations understand that longer lengths of stay often bring increased regulatory attention. The key is recognizing that longer stays are not inherently problematic when the medical record clearly demonstrates continued eligibility.

The Clinical Reality: Hospice Was Designed for More Than the Final Days

One of the biggest misconceptions about hospice is that a patient’s eligibility is determined by how long they ultimately remain on service. In reality, Medicare eligibility is based on a physician’s certification that the patient has a life expectancy of six months or less if the terminal illness follows its normal course. That six-month prognosis is not meant to predict exactly when a patient will die, nor does it mean hospice services automatically end after six months.

In fact, the Medicare Hospice Benefit was intentionally designed to allow patients to remain on hospice beyond six months if they continue to meet eligibility requirements. This is especially important for conditions like advanced dementia, COPD, heart failure, and neurological diseases, where decline is often gradual and unpredictable. Waiting for a dramatic change before making a referral can mean patients and families miss valuable opportunities for symptom management, caregiver education, psychosocial support, and advance care planning. Despite these benefits, many patients are still referred far too late to fully experience everything hospice has to offer.

The Regulatory Reality: Why Longer Lengths of Stay Receive Attention

While long hospice stays can be appropriate, they naturally receive greater attention from regulators because longer stays account for a significant portion of hospice utilization and Medicare spending.

CMS, the Office of Inspector General (OIG), and other oversight organizations continue to focus on hospice compliance, including whether medical records support ongoing eligibility and whether services billed align with Medicare requirements.This does not mean that a long length of stay automatically indicates inappropriate utilization.

A patient remaining on hospice for more than six months is not, by itself, a compliance concern. The question is whether the documentation tells a consistent clinical story supporting continued eligibility.

As hospice leaders know, the longer a patient remains on service, the more important it becomes to demonstrate the progression of disease through objective findings.

The medical record should reflect changes such as:

• Declining functional status
• Increased dependence with activities of daily living
• Nutritional decline
• Worsening cognition
• Increased symptom burden
• Progressive weakness or frailty
• Increased need for hospice interventions

The diagnosis may remain the same, but the patient’s overall condition should continue to demonstrate why hospice remains appropriate.

Why Length of Stay Alone Does Not Tell the Full Story

Length of stay by itself is not an accurate measure of whether hospice care is appropriate. While longer stays often receive additional attention from regulators, they are not automatically evidence of inappropriate admissions or poor compliance. Likewise, a shorter stay does not necessarily indicate better hospice utilization.

A healthy hospice census naturally includes a range of patient experiences. Some patients are admitted only days before death, while others with slowly progressive illnesses remain eligible for months because their decline continues over time. What matters is not reaching a target length of stay, but ensuring patients are admitted when they become eligible and remain on service only while the medical record clearly supports continued eligibility.

This distinction is especially important for diagnoses with less predictable disease trajectories. A patient with advanced dementia, for example, may not experience a single dramatic event that signals decline. Instead, continued eligibility may be demonstrated through worsening cognition, decreased intake, increasing dependence with activities of daily living, recurrent infections, weight loss, or progressive frailty. In these situations, the clinical narrative often tells the story far better than the diagnosis alone.

Where Regulatory Risk Actually Develops

The greatest regulatory risk is rarely the length of a patient’s stay itself. More often, it is the hospice documentation behind that stay. As patients move through multiple benefit periods, the medical record must continue to tell a clear, individualized story of disease progression and why hospice remains appropriate.

That includes more than physician narratives alone. Nursing documentation, interdisciplinary notes, face-to-face encounter documentation, and plans of care should all consistently reflect the patient’s ongoing decline. Generic recertification language or repeated documentation that shows little change over time can create unnecessary vulnerability during an audit.

Hospice leaders should also pay close attention to other areas that frequently receive additional scrutiny, including General Inpatient (GIP) utilization and aggregate cap management. GIP is intended for short-term management of acute symptoms that cannot be effectively controlled in another setting, so prolonged or frequent use should always be supported by thorough documentation. Similarly, organizations with a higher proportion of long-stay patients should proactively monitor aggregate cap performance and utilization trends. These issues are not inherently problematic, but they require thoughtful oversight and documentation that supports the clinical decisions being made.

How Hospice Leaders Can Balance Access and Compliance

Finding the right balance starts with building documentation practices that accurately reflect each patient’s individual journey. Rather than focusing solely on diagnoses, clinicians should clearly capture changes in functional status, nutritional decline, symptom burden, dependence with activities of daily living, and other objective indicators of progression. These details become increasingly important as patients remain on service longer.

At the organizational level, compliance should be proactive rather than reactive. Routine documentation education, adequate hospice care software system implementation and usage, interdisciplinary collaboration, and internal chart reviews help agencies identify opportunities for improvement long before an audit occurs. Monitoring trends in length of stay, referral patterns, diagnoses, and other utilization data can also help hospices better understand their patient population while supporting both quality care and regulatory readiness.

Perhaps most importantly, concerns about oversight should never discourage timely referrals for patients who are truly hospice eligible. Delaying admission because someone may live longer than expected can prevent patients and families from receiving the full benefit of hospice care. Appropriate admissions supported by strong clinical documentation remain the best way to balance compassionate care with compliance.

My Takeaways

One theme consistently rises to the surface whenever hospice length of stay is discussed: the goal is not shorter stays or longer stays. The goal is appropriate stays.

Patients deserve access to hospice as soon as they become eligible, not only during their final days. At the same time, hospice organizations have a responsibility to ensure the medical record clearly demonstrates continued eligibility throughout every benefit period. Those two priorities are not at odds with one another. In fact, strong, patient-centered documentation is what allows hospices to accomplish both.

Having worked closely with hospice administrators, clinicians, and care teams over the years, I know how much thought goes into balancing quality patient care with regulatory expectations. I also know that many organizations worry that admitting patients earlier may increase their regulatory risk. In reality, the issue is rarely that a patient lived longer than expected. More often, it comes down to whether the documentation clearly supports why that patient continued to qualify for hospice services.

The organizations that do this well are not focused on avoiding patients with potentially longer lengths of stay. They focus on admitting eligible patients at the right time, building strong clinical processes, educating their teams, and making sure every patient’s record accurately reflects their unique journey. When that foundation is in place, hospice providers can confidently deliver timely, compassionate care while protecting the integrity of the Medicare Hospice Benefit.

References

1. Medicare Payment Advisory Commission (MedPAC). Report to the Congress: Medicare Payment Policy, Chapter 12: Hospice Services. March 2019.
2. Centers for Medicare & Medicaid Services (CMS). Hospice Center: Medicare Hospice Benefit and Payment Information.
3. Centers for Medicare & Medicaid Services (CMS). CMS Proposes New Transparency Measures to Strengthen Oversight of Hospice Providers.
4. Office of Inspector General (OIG). Hospice Program Integrity: Review of Hospice Eligibility and Billing Documentation. Work Plan Project W-00-24-31577.
5. National Partnership for Hospice Innovation (NPHI). Hospice Medicare Margins. July 2019.

Other helpful blogs:

1. Hospice Audits – Preparing for increased scrutiny on eligibility and documentation
2. When the patient cannot sign, best practices for hospice admissions & more
3. Advanced care planning in hospice agencies
4. What are the crucial skills for home health and hospice hiring?
5. Selecting the best caregiver for end-of-life care
6. Understanding hospice eligibility beyond the basics